Electrogenomics Group Unravelling the electrical and genetic causes of cardiovascular mortality

About

The Electrogenomics group was established in 2015 by Professors Munroe, Lambiase, Tinker and Dr Orini, and initially funded by the Medical Research Council. Our research goal is to unravel the electrical and genetic causes of cardiovascular mortality. Since 2017, we have received funding and support from the BHF UKRI, NIHR and the EU. We are a collaborative group and based at the William Harvey Research Centre at QMUL, UCL Institute of Cardiovascular Science, University of Zaragoza, Kings College London and University of Oxford. Our team includes world-leading experts in cardiac electrophysiology, clinician scientists, biomedical engineering, computational medicine, genetics, epigenetics and functional genomics. Our group also comprises PhD students and Post-Doctoral researchers and we are very happy to host research internships and studentships.

Highlights

Our Team

Our Team

Our team includes world-leading experts in cardiac electrophysiology, clinician scientists, biomedical engineering, computational medicine, genetics, epigenetics and functional genomics. Our group also comprises PhD students and Post-Doctoral researchers and we are very happy to host research internships and studentships.

Our Research

Our Research

Our research activities and impactful public engagement efforts have been acknowledged through awards, funding and recognitions from leading conferences, consortia, institutions, and by press attention.

Our Publications

Our Publications

We study complex phenotypes of cardiac electrophysiology and response to heart rate dynamics. Building on recent publications by the group, further studies are underway to improve our understanding of the mechanisms linking genetics, functional biology, electrophysiology and cardiovascular disease, and the integration of these biomarkers to optimise risk prediction of cardiac events.

Funding

Medical Research Council (MR/N025083/1 and MR/R017468/1), People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Programme (FP7/2007/2013) under REA grant agreement 608765, the UCL/UCLH Biomedicine NIHR and the NIHR Cardiovascular Biomedical Research Centre at Barts and QMUL.